Luminii provides CDD to BGF on their investment in Evo
Luminii Consulting is delighted to have provided Commercial Due Diligence (CDD) support to BGF on its investment in Evo.
Evo is a surgical and high-precision engineering company that provides bespoke full jaw dental implant solutions in a day to patients has received a £4m investment from BGF. London-headquartered Evo will use the funding to expand its clinics, which feature on-site dental laboratories with the latest hi-tech medical manufacturing technology across the UK and explore international growth.
Evo’s advanced, proprietary solution provides life changing treatment for patients suffering from severe dental problems caused by advanced gum disease, congenital bone loss or accidents, and who require a full jaw reconstruction.
Designed and developed in-house by founder Dr R.P. Vijayanarayanan BDS (‘Vijay’) and a team of highly skilled dental surgeons, dental technicians and clinical CAD designers, Evo creates a bespoke new smile for every patient. The process features digital scanning, prosthesis manufacturing, 3D printing, and high-precision milling machines with an accuracy of below ten microns, which is on par with aerospace engineering.
The business has centres in Heathrow and Liverpool, and has completed more than 3,000 full-arch reconstructions for patients who have been referred by Evo’s growing network of dental practitioners or approached the company directly.
The team has the ability to treat 99 percent of people who receive a full clinical assessment, even if they have previously been told that their only option is dentures as they don’t have enough bone to anchor conventional dental implants. The Adult Dental Health survey and ONS data suggest that more than five million people in UK could benefit clinically from this treatment. Evo has seen increased demand from patients who want a permanent, comfortable and aesthetically appealing alternative.
BGF’s funding will be used to expand capacity at Evo’s current facilities, rollout new clinics in the UK and explore franchise opportunities internationally. Michael Lewis, who has held senior roles in growing businesses in the healthcare and medical devices sectors including Align Technologies, Cambridge Cognition, Glyconics and iPlato, has been appointed as Non-Executive Chairman.
Latest articles
- Luminii provides CDD support to Maven on their investment in Connected Data 07 Oct 2024
- Private Equity's Relentless Focus on Driving Value Creation in Portfolio Companies 26 Sep 2024
- Luminii shortlisted as Commercial Due Diligence Provider of the Year at British Private Equity Awards 2024 10 Sep 2024
- Luminii provides CDD support to Growth Partner on their investment in Host & Stay 06 Sep 2024
- Luminii provides CDD support to Octopus Ventures on their investment in Switchee 15 Jul 2024